Among UK Biobank participants with MRI, elevated liver cT1 and reduced left-ventricular ejection fraction independently—or in combination—predicted cardiovascular and liver events and all-cause mortality. Cardiac and hepatic impairment often coexisted, supporting multi-organ MRI as a tool for integrated risk stratification and prevention pathways spanning heart and liver disease.